Contract Manufacturing Industry News
-
Kindeva Drug Delivery And Cambridge Healthcare Innovations Limited To Collaborate On Development Of Novel Dry-Powder Inhaler Product
4/6/2021
Kindeva Drug Delivery L.P. (Kindeva) and Cambridge Healthcare Innovations Limited (CHI) have entered into a collaboration to develop and commercialize CHI’s αeolus dry-powder inhaler (DPI) platform technology. The collaboration will leverage Kindeva’s product development, regulatory affairs, and manufacturing capabilities in tandem with CHI’s DPI technology and device development expertise.
-
Ajinomoto Bio-Pharma Services Expands Manufacturing Agreement With AstraZeneca To Include Drug Product Manufacturing
3/30/2021
Ajinomoto Bio-Pharma Services, a leading provider of biopharmaceutical contract development and manufacturing services, announced a manufacturing agreement expansion with AstraZeneca to include drug product manufacturing.
-
Jubilant HollisterStier Announces COVID-19 Vaccine Candidate Manufacturing Agreement With Novavax
3/24/2021
Jubilant HollisterStier announced that it has entered into a non-exclusive manufacturing agreement with Novavax, a biotechnology company developing next-generation vaccines for serious infectious diseases, to provide fill-finish manufacturing services for the production of COVID-19 vaccine candidate NVX-CoV2373.
-
Jubilant HollisterStier Signs Manufacturing Agreement With Eli Lilly For COVID-19 Therapeutic Bamlanivimab
3/11/2021
Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, recently announced that its wholly-owned subsidiary, Jubilant Pharma Limited, through one of its subsidiaries, Jubilant HollisterStier LLC, has signed a new contract with Eli Lilly for contract manufacturing of a treatment for COVID-19.
-
Meissner Expands M-Flex™ TPE Tubing Portfolio
2/24/2021
Meissner is pleased to announce its expanded offering of TPE tubing for critical biopharmaceutical applications. Tubing shortages have been hampering manufacturing operations worldwide, and we are excited to help mitigate risk by offering a solution.
-
Stevanato Group Launches Artificial Intelligence Platform To Further Enhance Detection Performance Of Its Visual Inspection Machines
2/23/2021
Pharma companies can achieve up to 99.9% defect detection accuracy thanks to the integration of deep learning models and secure, cloud-based technology. A dedicated team will support customers throughout the machine's life cycle.
-
Thermo Fisher Scientific Opens New Site In Buenos Aires, Argentina
8/20/2019
The purpose built, state-of-the art facility will help address the growing demand for development supply chain services and will focus on high quality secondary packaging solutions for customers and their patients. The new site will provide clinical trial support services including GMP storage, local labeling, secondary packaging, comparator sourcing, and handling and distribution of ambient and cold chain clinical trial supplies through to returns management.
-
Thermo Fisher Scientific Opens New Laboratory To Support Sterile Drug Development
8/20/2019
Thermo Fisher Scientific expanded capacity at the North American site for sterile drug products in Greenville, NC and will now perform non-GMP work to support clinical phase programs. The new development laboratory features two Lyostar3 freeze dryers with SMART technology that are capable of decreasing the number of runs required for lyophilization cycle development.
-
Gains In Cardiac Rhythm Management Devices Offset By Lower Pricing
2/6/2013
The rising incidence of lifestyle diseases such as diabetes and obesity, an ageing population and the prevalence of cardiovascular diseases such as arrhythmia, heart failure and atrial fibrillation, have expanded the patient pool for cardiac rhythm management (CRM) devices in both Europe and the United States.
-
Dr. Reddy’s Laboratories Limited Intends To Make A Recommended Public Offer For Octoplus N.V.
10/22/2012
Dr. Reddy’s Laboratories Limited (“Dr. Reddy’s”), together with its subsidiaries, announces the intended public offer to acquire the issued and outstanding shares of OctoPlus N.V.